Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn’s disease-Reference-Cited by-同舟云学术

Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn’s disease

Published:2019-04-15 Issue:11 Volume:49 Page:1401-1409
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Novak Gregor¹²,Stevens Toer³^ORCID,Van Viegen Tanja¹,Bossuyt Peter⁴,Štabuc Borut²,Jeyarajah Jenny¹,Zou Guangyong¹⁵,Gaemers Ingrid C.⁶,McKee Trevor D.⁷,Fu Fred⁷,Shackelton Lisa M.¹^ORCID,Khanna Reena¹⁸,van den Brink Gijs R.³⁶,Sandborn William J.¹⁹^ORCID,Feagan Brian G.¹⁵⁸^ORCID,Pai Rish K.¹⁰,Jairath Vipul¹⁵⁸,Vande Casteele Niels¹⁹^ORCID,D’Haens Geert¹³

Affiliation:

1. Robarts Clinical Trials Inc; London ON Canada

2. Department of Gastroenterology; Ljubljana University Medical Centre, University of Ljubljana; Ljubljana Slovenia

3. Inflammatory Bowel Disease Centre; Academic Medical Center; Amsterdam The Netherlands

4. Imelda General Hospital; Bonheiden Belgium

5. Department of Epidemiology and Biostatistics; University of Western Ontario; London ON Canada

6. Amsterdam UMC; University of Amsterdam, Tytgat Institute for Liver and Intestinal Research; Amsterdam The Netherlands

7. STTARR Innovation Centre; University Health Network; Toronto ON Canada

8. Department of Medicine; University of Western Ontario; London ON Canada

9. Department of Medicine; University of California San Diego; La Jolla California

10. Department of Laboratory Medicine and Pathology; Mayo Clinic; Scottsdale Arizona

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15250/fullpdf

Reference41 articles.

1. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease;Baert;Gastroenterology,2010

2. Mucosal healing in Crohn's disease: a systematic review;Cruz;Inflamm Bowel Dis,2013

3. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial;D'Haens;Lancet,2008

4. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease;Schnitzler;Inflamm Bowel Dis,2009

5. Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease;Shah;Aliment Pharmacol Ther,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Crohn’s disease severity in the colon using mixed cell nucleus density from pseudo labels;Medical Imaging 2023: Digital and Computational Pathology;2023-04-07

2. Biopsies from ulcer edge yield higher histological activity scores than biopsies from non-ulcerated mucosa in active ulcerative colitis;European Journal of Gastroenterology & Hepatology;2023-03-18

3. Integrated omic techniques and their genomic features for invasive weeds;Functional & Integrative Genomics;2023-01-21

4. Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative;Endoscopy;2022-07-29

5. Carboxymethyl Chitosan Oligosaccharide Holds Promise for Treatment of Stenosis Crohn’s Disease;ACS Pharmacology & Translational Science;2022-07-20